EMEA (Europe, Middle East and Africa) Self-administered Drugs Market Report 2017

December 2017 | 108 pages | ID: E4C4E29ED5CEN
QYResearch

Abstracts

In this report, the EMEA Self-administered Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Self-administered Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Self-administered Drugs market competition by top manufacturers/players, with Self-administered Drugs sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abbott Laboratories
• Bristol-Myers Squibb
• Novartis AG
• Eli Lilly and Company
• Gilead Sciences
• Antares Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Injectable Drugs
• Inhaled Drugs
• Transdermal Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cardiovascular Diseases
• Diabetes
• Osteoporosis
• Pain Management
• Hormone Replacement
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Self-administered Drugs Market Report 2017

1 SELF-ADMINISTERED DRUGS OVERVIEW

1.1 Product Overview and Scope of Self-administered Drugs
1.2 Classification of Self-administered Drugs
  1.2.1 EMEA Self-administered Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Self-administered Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Injectable Drugs
  1.2.4 Inhaled Drugs
  1.2.5 Transdermal Drugs
1.3 EMEA Self-administered Drugs Market by Application/End Users
  1.3.1 EMEA Self-administered Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cardiovascular Diseases
  1.3.3 Diabetes
  1.3.4 Osteoporosis
  1.3.5 Pain Management
  1.3.6 Hormone Replacement
  1.3.7 Others
1.4 EMEA Self-administered Drugs Market by Region
  1.4.1 EMEA Self-administered Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Self-administered Drugs (2012-2022)
  1.5.1 EMEA Self-administered Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Self-administered Drugs Revenue and Growth Rate (2012-2022)

2 EMEA SELF-ADMINISTERED DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Self-administered Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Self-administered Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Self-administered Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Self-administered Drugs Sale Price by Players (2012-2017)
2.2 EMEA Self-administered Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Self-administered Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Self-administered Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Self-administered Drugs Sale Price by Type (2012-2017)
2.3 EMEA Self-administered Drugs (Volume) by Application
2.4 EMEA Self-administered Drugs (Volume and Value) by Region
  2.4.1 EMEA Self-administered Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Self-administered Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Self-administered Drugs Sales Price by Region (2012-2017)

3 EUROPE SELF-ADMINISTERED DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Self-administered Drugs Sales and Value (2012-2017)
  3.1.1 Europe Self-administered Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Self-administered Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Self-administered Drugs Sales and Market Share by Type
3.3 Europe Self-administered Drugs Sales and Market Share by Application
3.4 Europe Self-administered Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Self-administered Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Self-administered Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Self-administered Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Self-administered Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Self-administered Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Self-administered Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Self-administered Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Self-administered Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SELF-ADMINISTERED DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Self-administered Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Self-administered Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Self-administered Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Self-administered Drugs Sales and Market Share by Type
4.3 Middle East Self-administered Drugs Sales and Market Share by Application
4.4 Middle East Self-administered Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Self-administered Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Self-administered Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Self-administered Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Self-administered Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Self-administered Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Self-administered Drugs Sales and Growth Rate (2012-2017)

5 AFRICA SELF-ADMINISTERED DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Self-administered Drugs Sales and Value (2012-2017)
  5.1.1 Africa Self-administered Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Self-administered Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Self-administered Drugs Sales and Market Share by Type
5.3 Africa Self-administered Drugs Sales and Market Share by Application
5.4 Africa Self-administered Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Self-administered Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Self-administered Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Self-administered Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Self-administered Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Self-administered Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Self-administered Drugs Sales and Growth Rate (2012-2017)

6 EMEA SELF-ADMINISTERED DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Self-administered Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Self-administered Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Self-administered Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis AG Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly and Company
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Self-administered Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly and Company Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Gilead Sciences
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Self-administered Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Gilead Sciences Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Antares Pharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Self-administered Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Antares Pharma Self-administered Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 SELF-ADMINISTERED DRUGS MANUFACTURING COST ANALYSIS

7.1 Self-administered Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Self-administered Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Self-administered Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Self-administered Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SELF-ADMINISTERED DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Self-administered Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Self-administered Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Self-administered Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Self-administered Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Self-administered Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Self-administered Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Self-administered Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Self-administered Drugs
Figure EMEA Self-administered Drugs Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Self-administered Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Injectable Drugs Product Picture
Figure Inhaled Drugs Product Picture
Figure Transdermal Drugs Product Picture
Figure EMEA Self-administered Drugs Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Self-administered Drugs by Application in 2016
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Osteoporosis Examples
Table Key Downstream Customer in Osteoporosis
Figure Pain Management Examples
Table Key Downstream Customer in Pain Management
Figure Hormone Replacement Examples
Table Key Downstream Customer in Hormone Replacement
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Self-administered Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Self-administered Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Self-administered Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Self-administered Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Self-administered Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Self-administered Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Self-administered Drugs Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Self-administered Drugs Sales Share by Players (2012-2017)
Figure 2016 Self-administered Drugs Sales Share by Players
Figure 2017 Self-administered Drugs Sales Share by Players
Figure EMEA Self-administered Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Self-administered Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Self-administered Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Self-administered Drugs Revenue Share by Players
Table 2017 EMEA Self-administered Drugs Revenue Share by Players
Table EMEA Self-administered Drugs Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Self-administered Drugs Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Self-administered Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Self-administered Drugs by Type (2012-2017)
Figure EMEA Self-administered Drugs Sales Market Share by Type (2012-2017)
Table EMEA Self-administered Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Self-administered Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Self-administered Drugs by Type in 2016
Table EMEA Self-administered Drugs Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Self-administered Drugs Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Self-administered Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Self-administered Drugs by Application (2012-2017)
Figure EMEA Self-administered Drugs Sales Market Share by Application in 2016
Table EMEA Self-administered Drugs Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Self-administered Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Self-administered Drugs by Region (2012-2017)
Figure EMEA Self-administered Drugs Sales Market Share in 2016
Table EMEA Self-administered Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Self-administered Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Self-administered Drugs by Region (2012-2017)
Figure EMEA Self-administered Drugs Revenue Market Share Regions in 2016
Table EMEA Self-administered Drugs Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Self-administered Drugs Revenue and Growth Rate (2012-2017)
Table Europe Self-administered Drugs Sales (K MT) by Type (2012-2017)
Table Europe Self-administered Drugs Market Share by Type (2012-2017)
Figure Europe Self-administered Drugs Market Share by Type in 2016
Table Europe Self-administered Drugs Sales (K MT) by Application (2012-2017)
Table Europe Self-administered Drugs Market Share by Application (2012-2017)
Figure Europe Self-administered Drugs Market Share by Application in 2016
Table Europe Self-administered Drugs Sales (K MT) by Countries (2012-2017)
Table Europe Self-administered Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Self-administered Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Self-administered Drugs Sales Market Share by Countries in 2016
Table Europe Self-administered Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Self-administered Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Self-administered Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Self-administered Drugs Revenue Market Share by Countries in 2016
Figure Germany Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure France Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure UK Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Self-administered Drugs Sales (K MT) by Type (2012-2017)
Table Middle East Self-administered Drugs Market Share by Type (2012-2017)
Figure Middle East Self-administered Drugs Market Share by Type (2012-2017)
Table Middle East Self-administered Drugs Sales (K MT) by Applications (2012-2017)
Table Middle East Self-administered Drugs Market Share by Applications (2012-2017)
Figure Middle East Self-administered Drugs Sales Market Share by Application in 2016
Table Middle East Self-administered Drugs Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Self-administered Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Self-administered Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Self-administered Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Self-administered Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Self-administered Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Self-administered Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Self-administered Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Self-administered Drugs Sales (K MT) by Type (2012-2017)
Table Africa Self-administered Drugs Sales Market Share by Type (2012-2017)
Figure Africa Self-administered Drugs Sales Market Share by Type (2012-2017)
Figure Africa Self-administered Drugs Sales Market Share by Type in 2016
Table Africa Self-administered Drugs Sales (K MT) by Application (2012-2017)
Table Africa Self-administered Drugs Sales Market Share by Application (2012-2017)
Figure Africa Self-administered Drugs Sales Market Share by Application (2012-2017)
Table Africa Self-administered Drugs Sales Volume (K MT) by Countries (2012-2017)
Table Africa Self-administered Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Self-administered Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Self-administered Drugs Sales Market Share by Countries in 2016
Table Africa Self-administered Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Self-administered Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Self-administered Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Self-administered Drugs Revenue Market Share by Countries in 2016
Figure South Africa Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Table Abbott Laboratories Self-administered Drugs Basic Information List
Table Abbott Laboratories Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Laboratories Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Abbott Laboratories Self-administered Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Self-administered Drugs Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Self-administered Drugs Basic Information List
Table Bristol-Myers Squibb Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Self-administered Drugs Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Self-administered Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Self-administered Drugs Basic Information List
Table Novartis AG Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis AG Self-administered Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Self-administered Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Self-administered Drugs Basic Information List
Table Eli Lilly and Company Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Self-administered Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Self-administered Drugs Revenue Market Share in EMEA (2012-2017)
Table Gilead Sciences Self-administered Drugs Basic Information List
Table Gilead Sciences Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gilead Sciences Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Gilead Sciences Self-administered Drugs Sales Market Share in EMEA (2012-2017)
Figure Gilead Sciences Self-administered Drugs Revenue Market Share in EMEA (2012-2017)
Table Antares Pharma Self-administered Drugs Basic Information List
Table Antares Pharma Self-administered Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Antares Pharma Self-administered Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Antares Pharma Self-administered Drugs Sales Market Share in EMEA (2012-2017)
Figure Antares Pharma Self-administered Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Self-administered Drugs
Figure Manufacturing Process Analysis of Self-administered Drugs
Figure Self-administered Drugs Industrial Chain Analysis
Table Raw Materials Sources of Self-administered Drugs Major Manufacturers in 2016
Table Major Buyers of Self-administered Drugs
Table Distributors/Traders List
Figure EMEA Self-administered Drugs Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Self-administered Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Self-administered Drugs Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Self-administered Drugs Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Self-administered Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Self-administered Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Self-administered Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Self-administered Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Self-administered Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Self-administered Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Self-administered Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Self-administered Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Self-administered Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Self-administered Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Self-administered Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Self-administered Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Self-administered Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Self-administered Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Self-administered Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Self-administered Drugs Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Self-administered Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Self-administered Drugs Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Self-administered Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources